Technology News and Research

RSS

Gen-Probe receives FDA emergency use authorization for its Prodesse ProFlu-ST test

Gen-Probe Incorporated today announced that the US Food and Drug Administration (FDA) has granted an EUA (emergency use authorization) for its test, the Prodesse ProFlu-ST(TM), to be used in CLIA high complexity laboratories for the diagnosis of 2009 H1N1 influenza virus infection, aided by an algorithm that relies on seasonal influenza A/H1 virus and seasonal influenza A/H3 virus results, from a single sample in individuals who are diagnosed with influenza A by currently available FDA-cleared or authorized devices.

29 Oct 2009

GeneGo to launch new web site with high quality pathway content

GeneGo, Inc., the leading systems biology tools company, announced today that they will be launching a new web site with FREE high quality pathway content. On www.genego.com, anyone can now search for genes, proteins, compounds, processes and diseases and access high quality manually curated pathway maps for human, mouse and rat signaling and metabolism.

29 Oct 2009

Encision announces financial results for its second quarter of fiscal year 2010

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported its financial results for its second quarter of fiscal year 2010.

29 Oct 2009

Third-quarter fiscal 2009 results announced by Curis

Curis, Inc., a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today reported its financial results for the third quarter ended September 30, 2009.

29 Oct 2009

Non-surgical alternative treatment for moderate to advanced gum disease announced

BIOLASE Technology, Inc. today announced its new Deep Pocket Therapy with New Attachment™ using the Waterlase MD™ and patented Radial Firing Perio Tips™ (RFPT) for a non-surgical alternative treatment for moderate to advanced gum disease.

29 Oct 2009

Activaero announces closing of a € 10.7M Series A financing

Activaero GmbH, the leading company in the field of controlled breathing technologies for inhaled therapeutic agents, announced today the closing of a Series A financing totalling € 10.7 Million ($16 million). The international consortium was led by BioMedPartners AG (advising BioMedInvest LP II) and included VI Partners AG, Abalis Finance AG and Vesalius Biocapital I SICAR S.A.. The transaction was advised by MedVenture Partners GmbH.

29 Oct 2009

GeckoSystems first annual conference to discuss its extensible low-level hierarchal architecture

GeckoSystems Intl. Corp. announced today that during their first annual "Mobile Robots in Motion" conference November 4-5, 2009 attendees will be able to observe and discuss GeckoSystems' extensible low-level hierarchal architecture.

29 Oct 2009

BIO's data shows the importance of university/industry research and development partnerships to the U.S. economy

A study released today by the Biotechnology Industry Organization (BIO) provides first-of-its-kind data on the importance of university/industry research and development partnerships to the U.S. economy.

29 Oct 2009

Simcere Pharmaceutical Group to control a 50.77% stake in Jiangsu Yanshen

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has entered into an agreement to acquire a 74.49% stake in ChinaVax, a Cayman Islands company that, as its sole business, holds a 13.27% stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").

29 Oct 2009

Legislation on Assisted Reproductive Technology proposed by the ICMR discussed

Vinay Menon of Mumbai, India-based law firm Menon & Associates (www.menonlawassociates.com) and Indian Counsel for Proactive Family Solutions was among the panel speakers on this topic at the Fall Conference of the American Bar Association Section of Family Law recently held in Montreal, Canada.

29 Oct 2009

Residents can serve a vital role in promoting CT colonography awareness

Residents can serve a vital role in educating Congress, the medical community, and the general public regarding the efficacy of cutting-edge technologies like CT colonography (CTC) as well as the importance of radiologists' training and education and the role that radiologists serve in the provision of quality health care, according to an article published in the November issue of the Journal of the American College of Radiology (JACR).

29 Oct 2009

Sweep Technology, a new way for adjusting hearing aids

Starkey Laboratories, Inc., one of the world’s leading hearing technology companies, is excited to introduce Sweep™ Technology – providing a completely new way to adjust hearing aids.

29 Oct 2009

CytRx study reveals potential of molecular chaperones in design of anti-aging pharmaceuticals

CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a “significant strategy” in the future design of anti-aging pharmaceuticals.

29 Oct 2009

Fresenius Kabi to license its proprietary HESylation Technology to Octapharma

Octapharma Group and Fresenius Kabi have signed a License, Development and Supply Agreement regarding the use of Fresenius Kabi's HESylation® Technology to develop a HESylated recombinant protein.

29 Oct 2009

CNS Protein Therapeutics changes its corporate name to Amarantus Therapeutics

CNS Protein Therapeutics, Inc., a privately held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death associated with a wide range of diseases, has completed a corporate name change to Amarantus Therapeutics, Inc. (“Amarantus”) and appointed prominent biotechnology industry executive, Martin D. Cleary, as Chief Executive Officer.

29 Oct 2009

Sangamo BioSciences awarded a grant to develop zinc finger nuclease-based stem cell therapy for AIDS

Sangamo BioSciences, Inc. announced today that the California Institute for Regenerative Medicine (CIRM) has granted a $14.5 million Disease Team Research Award to develop an AIDS-related lymphoma therapy based on the application of its zinc finger nuclease (ZFN) gene-editing technology in stem cells.

29 Oct 2009

Repros Therapeutics amends its existing license for Proellex

Repros Therapeutics today announced that the Company has entered into an amendment with the National Institutes of Health (NIH) to its existing exclusive license for Proellex® that revises the existing milestones and dates for performance to provide additional time to lift the current clinical hold on Proellex or select a second generation molecule for further development from the family of anti-progestational agents covered by the license.

29 Oct 2009

Praxis Version 5 featuring Datum released

Infor-Med Corporation, makers of Praxis Electronic Medical Records (EMR), announced today the beta release of Praxis Version 5 featuring Datum, a tool that allows physicians to use free text to create, store, and share discrete clinical data.

29 Oct 2009

Interpreters at UNC Hospitals carry iPod Touch to stay connected

Pagers are ubiquitous in the hospital setting. They are so familiar and common, in fact, that they are even used for comic effect on medically themed TV dramas such as "House M.D."

29 Oct 2009

AMT inks agreement with Progenika Biopharma for development of LPLchip

Amsterdam Molecular Therapeutics (AMT) and Progenika Biopharma announced today that the companies have entered into a development and commercialization agreement for LPLchip(TM), a diagnostic tool to rapidly diagnose patients with complete and partial lipoprotein lipase deficiency (LPLD). AMT has developed Glybera(R) as a gene therapy for patients with this disease.

29 Oct 2009